Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frode Selheim

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Medicinal Chemistry|November 14, 2019
Targeted and Immune-Based Therapies for Acute Myeloid Leukemia: Inflammatory Signaling and Multiple Post-Translational ModificationsFrode Selheim
Current Pharmaceutical Biotechnology|August 28, 2015
Editorial: Toward Personalized Treatment for Acute Myeloid LeukemiaFrode Selheim, Lars Herfindal
Mini Reviews in Medicinal Chemistry|March 7, 2006
Microcystin produces disparate effects on liver cells in a dose dependent mannerLars Herfindal, Frode Selheim
FEBS Letters|February 20, 2002
Identification of functional VEGF receptors on human plateletsFrode Selheim, Holm Holmsen, Flemming S Vassbotn
International Journal of Molecular Sciences|September 22, 2020
The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and PerspectivesMaria Hernandez-Valladares, Øystein Bruserud, Frode Selheim
Cancers|January 21, 2023
Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right StepsPaula Carrillo-Rodriguez, Frode Selheim, Maria Hernandez-Valladares
Analytica Chimica Acta|December 20, 2011
Minimization of side reactions during Lys Tag derivatization of C-terminal lysine peptidesOlav Mjaavatten, Gyrid Nygaard, Frode S Berven, et al.
Cancers|January 11, 2024
High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5Frode Selheim, Elise Aasebø, Øystein Bruserud, et al.
FEBS Letters|June 28, 2003
cAMP effector mechanisms. Novel twists for an 'old' signaling systemReidun Kopperud, Camilla Krakstad, Frode Selheim, et al.
Biomolecules|February 26, 2025
XPO1/Exportin-1 in Acute Myelogenous Leukemia; Biology and Therapeutic TargetingØystein Bruserud, Frode Selheim, Maria Hernandez-Valladares, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Medicinal Chemistry|November 14, 2019
Targeted and Immune-Based Therapies for Acute Myeloid Leukemia: Inflammatory Signaling and Multiple Post-Translational ModificationsFrode Selheim
Current Pharmaceutical Biotechnology|August 28, 2015
Editorial: Toward Personalized Treatment for Acute Myeloid LeukemiaFrode Selheim, Lars Herfindal
Mini Reviews in Medicinal Chemistry|March 7, 2006
Microcystin produces disparate effects on liver cells in a dose dependent mannerLars Herfindal, Frode Selheim
FEBS Letters|February 20, 2002
Identification of functional VEGF receptors on human plateletsFrode Selheim, Holm Holmsen, Flemming S Vassbotn
International Journal of Molecular Sciences|September 22, 2020
The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and PerspectivesMaria Hernandez-Valladares, Øystein Bruserud, Frode Selheim
Cancers|January 21, 2023
Mass Spectrometry-Based Proteomics Workflows in Cancer Research: The Relevance of Choosing the Right StepsPaula Carrillo-Rodriguez, Frode Selheim, Maria Hernandez-Valladares
Analytica Chimica Acta|December 20, 2011
Minimization of side reactions during Lys Tag derivatization of C-terminal lysine peptidesOlav Mjaavatten, Gyrid Nygaard, Frode S Berven, et al.
Cancers|January 11, 2024
High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5Frode Selheim, Elise Aasebø, Øystein Bruserud, et al.
FEBS Letters|June 28, 2003
cAMP effector mechanisms. Novel twists for an 'old' signaling systemReidun Kopperud, Camilla Krakstad, Frode Selheim, et al.
Biomolecules|February 26, 2025
XPO1/Exportin-1 in Acute Myelogenous Leukemia; Biology and Therapeutic TargetingØystein Bruserud, Frode Selheim, Maria Hernandez-Valladares, et al.
Pageof 7